Daewoong Pharmaceutical (India) Profile
Key Indicators
- Authorised Capital ₹ 2.90 Cr
- Paid Up Capital ₹ 2.86 Cr
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 3.07%
- Profit Growth -22.52%
- Ebitda 59.37%
- Net Worth 10.49%
- Total Assets 159.39%
About Daewoong Pharmaceutical (India)
Daewoong Pharmaceutical (India) Private Limited (DPIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 30 November 2012 and has a history of 12 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.90 Cr and a paid-up capital of Rs 2.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chung Song, Gwan Kim, and Neelima Aryasomayajula serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2012FTC084511
- Company No.
084511
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
30 Nov 2012
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Daewoong Pharmaceutical (India) Private Limited
Explore comprehensive data for Daewoong Pharmaceutical (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Daewoong Pharmaceutical (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chung Song  | Director | 08-Feb-2016 | Current |
| Gwan Kim | Director | 09-Apr-2018 | Current |
Neelima Aryasomayajula  | Additional Director | 23-May-2024 | Current |
Financial Performance of Daewoong Pharmaceutical (India).
Daewoong Pharmaceutical (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.07% increase. The company also saw a substantial fall in profitability, with a 22.52% decrease in profit. The company's net worth Soared by an impressive increase of 10.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daewoong Pharmaceutical (India)?
In 2023, Daewoong Pharmaceutical (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cg Medtech India Private Limited
Chung Song is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daewoong Pharmaceutical (India)?
Daewoong Pharmaceutical (India) has a workforce of 23 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daewoong Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daewoong Pharmaceutical (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Daewoong Pharmaceutical (India)
Recent activity within the organization
- Director Appointment
Neelima Aryasomayajula was appointed as a Additional Director was appointed as a Additional Director on 23 May 2024 & has been associated with this company since 11 months 10 days .
- Annual General Meeting
Daewoong Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
- Balance Sheet
Daewoong Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Gwan Young Kim was appointed as a Director was appointed as a Director on 09 Apr 2018 & has been associated with this company since 7 years 24 days .
- Director Appointment
Chung Hyun Song was appointed as a Director was appointed as a Director on 08 Feb 2016 & has been associated with this company since 9 years 2 months .
- Company Incorporation
Daewoong Pharmaceutical (India) Private Limited was registered on 30 Nov 2012 with Roc Hyderabad & aged 12 years 5 months as per MCA records.
Recent News, Updates & Announcement
- Daewoong Pharmaceutical's Fexuprazan entering into a partnership with Cooper Pharma.
No. 1 pharmaceutical company in Morocco in the field of digestive health .
Frequently asked questions
What is the Incorporation or founding date of Daewoong Pharmaceutical (India) Private Limited?
Daewoong Pharmaceutical (India) Private Limited was incorporated on 30 Nov 2012.
What is authorized share capital and paid-up capital of Daewoong Pharmaceutical (India) Private Limited?
The authorized share capital of Daewoong Pharmaceutical (India) Private Limited is ₹ 2.90 Cr and paid-up capital is ₹ 2.86 Cr.
Who are the current board members & directors of Daewoong Pharmaceutical (India) Private Limited?
Currently 3 directors are associated with Daewoong Pharmaceutical (India) Private Limited.
- Chung Hyun Song
- Gwan Young Kim
- Neelima Aryasomayajula
What is the registered address of Daewoong Pharmaceutical (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Daewoong Pharmaceutical (India) Private Limited is Plot No.5A, A.P.I.I.C Kukatpally India, Hyderabad, Telangana, 500072.
What is the corporate identification number (CIN) and company number of Daewoong Pharmaceutical (India) Private Limited?
The corporate identification number (CIN) of Daewoong Pharmaceutical (India) Private Limited is U24232TG2012FTC084511 and the company number is 084511 as per Ministry of Corporate Affairs (MCA).
What is the official website of Daewoong Pharmaceutical (India) Private Limited?
The Official website of Daewoong Pharmaceutical (India) Private Limited is https://www.daewoong.com
What has been the recent revenue trend for Daewoong Pharmaceutical (India) Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Daewoong Pharmaceutical (India) Private Limited has risen by 3.07%.
How many employees does Daewoong Pharmaceutical (India) Private Limited currently have?
As Per 2023 financial reports, 23 employees are currently employed by Daewoong Pharmaceutical (India) Private Limited.
What change has been observed in the net worth of Daewoong Pharmaceutical (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Daewoong Pharmaceutical (India) Private Limited has experienced an upsurge of 10.49%.
When was the last Balance Sheet of Daewoong Pharmaceutical (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Daewoong Pharmaceutical (India) Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India